Takeda Pharmaceutical Co Ltd (SSE:4502)
円 4300 0 (0%) Market Cap: 6.48 Til Enterprise Value: 10.85 Til PE Ratio: 36.14 PB Ratio: 0.88 GF Score: 74/100

Takeda Pharmaceutical Co Ltd at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 07:35PM GMT
Release Date Price: 円4400
Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

Good afternoon. My name is Shinichiro Muraoka, covering Japanese pharma in Morgan Stanley Japan Pharma team. Today, in this session we were with Takeda. Well, I'm extremely pleased to have Costa Saroukos, CFO of Takeda; and Andy Plump, President of R&D. Costa and Andy, thank you for joining us today.

Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director

Thank you, Muraoka, for having us. Appreciate it.

Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

Thank you. So sorry, before starting this session, important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/disclosures.

Questions & Answers

Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

So okay, let's get started with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot